Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Sekula-Gibbs S, Uptmore D, Otillar L
Tapering GLP-1s may not be right for everyone, but the researchers suggest it may help reduce long-term medication use
Similarly, for kidney health, the FLOW trial demonstrated that semaglutide reduced the risk of severe kidney outcomes, including kidney failure and death, by 24% (HR 0.76, 95% CI 0.660.88)
(2024) A pilot study of senolytics to improve cognition and mobility in older adults at risk for Alzheimers disease
US$ 22.66
US$ 28.27
US$ 26.28
US$ 20.42
US$ 23.85
US$ 27.65
US$ 27.23
US$ 23.19
US$ 22.60
US$ 24.91
